A new publication dated September 2, 2026 discusses teriparatide in the context of osteoporosis treatment. The article, titled "Teriparatide treatment of osteoporosis in solid organ transplant recipients-a single-center experience," appears in the journal Archives of Osteoporosis.
The publication describes a single-center experience involving solid organ transplant recipients treated with teriparatide for osteoporosis. No additional details about study design, outcomes, or findings were provided beyond the title and journal listing.
Teriparatide is an approved compound. This entry reflects only the existence and bibliographic details of this new publication, not its content or conclusions.
Readers interested in this topic can consult the compound overview for additional context on teriparatide.